SFS
BMRN icon

Sowell Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Sowell Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-487
Closed -$38K – 802
2021
Q1 		$38K Buy
487
+69
+17% +$5.64K ﹤0.01% 1767
2020
Q4 		$37K Buy
418
+122
+41% +$9.67K ﹤0.01% 1507
2020
Q3 		$23K Sell
296
-27
-8% -$2.73K ﹤0.01% 1493
2020
Q2 		$40K Sell
323
-9
-3% -$894 ﹤0.01% 1228
2020
Q1 		$28K Buy
332
+89
+37% +$7.67K ﹤0.01% 1264
2019
Q4 		$21K Sell
243
-48
-16% -$3.63K ﹤0.01% 1413
2019
Q3 		$20K Buy
+291
New +$22.4K ﹤0.01% 1273

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return